Showing results (301-310 of 361) with videos related to

Sort By:
Pageof 37
Neoplasia (New York, N.Y.)|September 26, 2025
Generation of orthotopic intracranial glioblastoma patient-derived xenograft models: insights into extrachromosomal DNA-driven MYC(N) and PDGFRA oncogene amplification and preliminary therapeutic evaluationThi-Anh-Thuy Tran, Sinae An, Junghyun Lim, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
BMJ Public Health|August 22, 2025
Non-medical costs incurred by critically ill patients with dengue, sepsis and tetanus within a major referral hospital in Southern Vietnam: a cost of illness studyTrinh Manh Hung, Thanh Nguyen Nguyen, Mau Toan Le, et al.
Scientific Reports|November 25, 2025
Prevalence and factors associated with metabolic syndrome and its components among overweight and obese reproductive-age women in Bac Giang, VietnamTuyet Thi Anh Doan, Tu Song Nguyen, Van Khanh Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2025
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain MetastasesSarah A Weiss, Dijana Djureinovic, Wei Wei, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 4, 2016
The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysisGeorgios A Margonis, Stefan Buettner, Kazunari Sasaki, et al.
BMJ Open|January 5, 2020
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trialGreg J Fox, Cam Binh Nguyen, Thu Anh Nguyen, et al.
The AAPS Journal|November 27, 2020
Correction to: Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry PerspectiveArian Emami Riedmaier, Kevin DeMent, James Huckle, et al.
The AAPS Journal|September 27, 2020
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry PerspectiveArian Emami Riedmaier, Kevin DeMent, James Huckle, et al.
Frontiers in Immunology|January 27, 2023
Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse modelThi-Anh-Thuy Tran, Young-Hee Kim, Thi-Hoang-Oanh Duong, et al.
Pageof 37